London, UK (PRWEB) September 21, 2012
Besides offering unique advantages, new molecular and genetic diagnostic tests also bring a tidal wave of complexity, cost, and quality issues for health plans. Given the magnitude of these challenges, molecular diagnosticс testing could be one of the biggest game changers health care has witnessed in decades.
New market research report “Analysis of Emerging Molecular Diagnostics Tests and Strategic Profiles of Leading Suppliers” developed by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.
Report Details:
Title: Analysis of Emerging Molecular Diagnostics Tests and Strategic Profiles of Leading Suppliers
Published: September, 2012
Pages: 548
Price: US$ 4,750.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/analysis-of-emerging-molecular-diagnostics-tests-n-strategic-profiles-of-leading-suppliers.html
The research report sheds light on the clinical significance and market needs for major current & emerging tests, besides offering extensive listings of 42 companies developing and marketing molecular diagnostic technologies and products.
The strategic assessment of current & emerging suppliers of molecular diagnostic products is carried out through their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Report Contents:
Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
AIDS
Structure and Composition
Classification
AIDS Origins
Animal Lentivirus Systems
Virus Receptors
HIV Infections in Humans
Pathogenesis and Pathology
CD4T Lymphocytes and Memory Cells
Monocytes and Macrophages
Lymphoid Organs
Neural Cells
Viral Coinfections
Clinical Findings
Plasma Viral Load
Pediatric AIDS
Neurologic Disease
Opportunistic Infections
Cancer
Immunity
Virus Isolation
Serology
Viral Nucleic Acid/Antigen Detection
Epidemiology
Worldwide Spread of AIDS
United States
Routes of Transmission
DNA Probes
Overview
Quantitative PCR
In Situ PCR
Needed Improvements
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Considerations
Adenovirus
Background
Diagnostic Tests
Vaccines and Drugs
Adeno-Associated Viruses (AAV)
Anthrax/Bacillus Anthracis
Background
Diagnostic Tests
Vaccines and Drugs
Babesiosis
Background
BEA and Other Bartonella Diseases
Background
Diagnostic Tests
Vaccines and Drugs
Chagas Disease
Background
Campylobacter
Background
Diagnostic Tests
Culture Identification
Vaccines and Drugs
Chlamydia
Background
Chlamydia psittaci
Chlmaydia pneumoniae
Chlamydia trachomatis
Diagnostic Tests
Vaccines and Drugs
Creutzfeldt-Jakob’s Disease
Background
Blood Transmission
Diagnostic Tests
Major Commercial and Academic Players
Bayer
Disease Sciences/Bi-Tec Global
Imperial College School of Medicine
Ortho-Clinical Diagnostics
Pall
ProMetic Life Sciences
Proteome Sciences/Idexx
Q-One Biotech
Serono
U.S. Agricultural Research Service
Drugs
Vaccines
Cytomegalovirus
Background
Chorioretinitis
Gastrointestinal
Central Nervous System Disease
Diagnostic Tests
Vaccines and Drugs
Ebola Virus
Background
Epidemiology
Clinical Syndromes
Diagnostic Tests
Vaccines and Drugs
EchoVirus
Background
Acute Aseptic Meningitisis
Encephalitis
Exanthems
...
More new market research reports by the publisher can be found at VPG page.